SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-22-000204
Filing Date
2022-03-25
Accepted
2022-03-24 20:17:32
Documents
13
Period of Report
2022-03-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nptx032422form8k.htm   iXBRL 8-K 32031
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 31021
  Complete submission text file 0001607062-22-000204.txt   239432

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nptx-20220321.xsd EX-101.SCH 3042
4 XBRL LABEL FILE nptx-20220321_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE nptx-20220321_pre.xml EX-101.PRE 22601
7 EXTRACTED XBRL INSTANCE DOCUMENT nptx032422form8k_htm.xml XML 3320
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 858-883-2642
NEUROPATHIX, INC. (Filer) CIK: 0001615999 (see all company filings)

IRS No.: 462645343 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55657 | Film No.: 22767962
SIC: 2834 Pharmaceutical Preparations